Home | Burnet Institute

What we do

Alcohol and other drugs Health emergencies and pandemic response Healthy ageing and non-communicable diseases Hepatitis B and C HIV Malaria and other mosquito-borne diseases Sexual and reproductive health Tuberculosis, COVID-19 and other airborne pathogens Women's and children's health Young people's health

Latest news

View 343 more

Global project aiming to 'break down' hepatitis C

On World Hepatitis Day, Burnet is actively supporting this year’s theme – ‘Let’s Break It Down’ – through our partnership in a global program to develop high-quality approaches to testing and treatment.

Burnet researcher developing first human organoid structure to study malaria

Dr Mayimuna Nalubega’s work is hoped to accelerate progress toward more effective vaccines and transform how scientists understand malaria immunity.

Paul Dietze and his amazing technicolour HIV lab coat

Professor Paul Dietze has a unique memento from IAS2025, a custom-designed lab coat reimagined through the lens of #HIV science, fashion, and activism.

View 343 more

How we make a difference

100x

more effective antibody treatments with our Stellabody® technology

Stellabody® technology →

50%

reduction in hepatitis C prevalence, through our partnership with Eliminate Hepatitis C (EC) Australia

Eliminate Hepatitis C Australia (EC Australia) →

20+

countries where we work with international partners

Where we work →

Across the Pacific, HIV is claiming more lives than ever

Help stop the epidemic by donating today.

Donate and help stop HIV

Projects

View 315 more

TRYP: Transitions and Risk in Young People

We aim to understand how the transition from adolescence to adulthood can influence health risks for young people, and how to intervene to reduce associated harms.